Abstract
Background
Anti-neuronal antibody Anti-Ri may be positive in patients with paraneoplastic syndrome associated with certain cancer subtypes. Anti-Ri positivity has been associated with breast, gynaecological and small cell lung cancers.
Case report
A 69 year-old female presented with a sudden decline in cognition requiring hospital admission. She had an extensive medical history including a significant smoking history and bipolar affective disorder for which she was prescribed lithium. Her cognitive decline was initially attributed to diabetes insipidus secondary to lithium therapy. She made a slow but gradual recovery with treatment. Additional investigations revealed positive Anti-Ri antibody. An occult malignancy screen identified enlarged aorto-pulmonary lymph nodes of indeterminate significance. Following discussion at the regional cardiothoracic multidisciplinary team meeting, three monthly surveillance scans were performed. At month 6 an increase in thoracic adenopathy was seen however endobronchial ultrasound guided biopsy failed to identify malignant cells. Further progression with new supraclavicular adenopathy was seen on repeat imaging 6 months later. A fine need aspirate of an enlarged supraclavicular lymph node was diagnostic for small cell lung cancer, staged as TxN3M0 on positron emission tomography. The patient went on to receive sequential chemo-radiotherapy with a truncated course of carboplatin and etoposide and 50 Gy/25 fractions of thoracic radiotherapy.
Discussion
This case suggests that a positive Anti-Ri antibody may predate the development of clinical or radiological evidence of malignancy. If Anti-Ri positivity is identified, strong consideration should be given to screening for malignancy and regular surveillance. This approach may lead to earlier diagnosis and a better outcome for these patients.
Similar content being viewed by others
References
Klaas JP et al (2012) Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol 69(12):1598–1607. doi:10.1001/archneurol.2012.1173
Tay JK et al (2012) Anti-Ri-associated paraneoplastic cerebellar and brainstem degenerative syndrome. J R Coll Physicians Edinb 42(3):221–224. doi:10.4997/JRCPE.2012.307
White D et al (2010) Paraneoplastic limbic encephalitis in an elderly patient with small cell lung carcinoma. Ulster Med J 79(1):22–24
Lugue FA et al (1991) Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29(3):241–251
Moll JW et al (1990) Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system. J Neurol Neurosurg Psychiatry 53(11):940–943
Rees J (2004) Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage. J Neurol Neurosurg Psychiatry 75(2):ii43–ii50
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Compliance with ethical standards
The authors of this paper declare no conflicts of interest. This article does not contain any studies with human participants performed by the authors.
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
O’Leary, C.G., Battley, J.E. & O’Reilly, S. Anti-Ri antibody associated small cell lung carcinoma. Ir J Med Sci 186, 265–267 (2017). https://doi.org/10.1007/s11845-016-1402-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-016-1402-1